Table 4.
Females | P | ||||||
---|---|---|---|---|---|---|---|
ALD group (n = 40) | Control group (n = 13) | ||||||
Median | 95% CI | 25–75 P | Median | 95% CI | 25–75 P | ||
Acrp30 µg/mL | 17.93 | 15.76–30.09 | 13.06–48.37 | 7.78 | 6.35–24.81 | 6.71–24.81 | 0.02 |
Leptin ng/mL | 6.80 | 3.30–11.00 | 2.55–13.00 | 16.64 | 5.13–42.10 | 5.13–42.10 | 0.009 |
Resistin ng/mL | 16.18 | 11.42–17.05 | 8.89–19.22 | 9.88 | 6.30–10.73 | 6.30–10.45 | 0.01 |
| |||||||
Males | P | ||||||
ALD group (n = 107) | Control group (n = 17) | ||||||
Median | 95% CI | 25–75 P | Median | 95% CI | 25–75 P | ||
| |||||||
Acrp30 µg/mL | 18.89 | 16.93–24.83 | 13.17–43.94 | 4.06 | 3.59–6.38 | 3.59–6.38 | <0.0001 |
Leptin ng/mL | 9.45 | 7.82–10.88 | 3.40–14.96 | 8.57 | 1.79–9.17 | 1.79–8.97 | 0.17 |
Resistin ng/mL | 17.69 | 15.36–21.58 | 11.08–31.17 | 8.87 | 8.36–15.12 | 8.36–15.12 | 0.005 |